Forex Education Symbols

37.375 -0.625 (-1.645%) 10/18/2017 4:37pm
Open: 37.800 Prev Close: 38.000
High: 38.240 Low: 37.000
Volume: 165517 Market Cap: 222.05M
Year High: 39.500 Year Low: 19.500
Stock Technical Analysis
Targets Six months: 45.20    One year: 52.80
Supports Support1: 29.80   Support2: 24.30
Resistances Resistance1: 38.70    Resistance2: 45.20 
Pivot Point 35.67 
Moving Averages MA(5): 37.72      MA(20): 34.98 

MA(100): 29.50      MA(250): 26.596 
MACD MACD(12,26): 1.79      Signal(12,26,9): 1.61 
Stochastic Oscillator %K(14,3): 93.55      %D(3): 94.38 
RSI RSI(14): 74.32 
52-Week High: 38.70  Low: 19.50  Change(%): 52.6
Average Volume(K) 3-Month: 12995  10-Days: 154.116196
Moving Averages analysis
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
Bollinger Bands Analysis
AGY.L has closed below upper band by 31.8%. Bollinger Bands are 152.3% wider than normal. The large width of the bands suggest high volatility as compared to AGY.L's normal range. The bands have been in this wide range for 7 bars. This is a sign that the current trend might continue.
Stock News
Allergy Therapeutics: Trading Update
Tue, 18 Jul 2017 06:11:15 GMT

Allergy Therapeutics strengthens clinical research team with senior appointments
Mon, 11 Sep 2017 06:30:14 GMT

Share Activity Lifted for Allergy Therapeutics Plc (AGY.L) in Session
Wed, 18 Oct 2017 12:26:42 GMT

Allergy Therapeutics set to begin phase II trial of PQ Grass hay fever ...
Mon, 18 Sep 2017 07:28:40 GMT

Allergy Therapeutics PLC Announces Novel House Dust Mite Allergy Vaccine Gains ...
Tue, 14 Feb 2017 06:56:15 GMT

Allergy Therapeutics confident of further growth
Wed, 29 Mar 2017 07:24:02 GMT

Stoxline Canada

Stock Chart London

Option Calculator

EPS Est. Current Year
EPS Est. Next Year
EPS Est. Next Quarter
Forward EPS
Shares Out. (M)
Shares Float (M) 2.31
Book Value (p.s.)
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)
P/E -4.09
P/E Growth Ratio